Medical Communication

Archive for October, 2009

Speaker list- FDA public hearing on Social media

Posted by drneelesh on October 30, 2009

In continuation of my last post on FDA meet regarding “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools” hearing, Heres the schedule and speaker list.Kindly note that this is only the first version and likely to be tweaked later depending on speaker availability at that time.

Hearing Date:  November 12 and 13, 2009
Hearing Name:  Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools
Location:  National Transportation and Safety Board Conference Center, 429 L’Enfant Plaza, SW., Washington, DC 20594

FDA Public Hearing Speaker Schedule

There are other ways to stay informed–

Related articles

Posted in FDA, health, Social Media | Leave a Comment »

Youtube for pharma marketing.- Best practices

Posted by drneelesh on October 29, 2009

YouTube, LLC

Recently read this post from Rohit Bhargava  titled “10 Rules Of Using YouTube For Pharma & Healthcare Marketing“. Though I don’t back all his logic, i found many of his views very important and worth repeating in another post. I have taken the liberty to add a few extra notes, while editing  many of his.
Youtube is a great channel for marketing and many Pharmaceutical companies are already actively involved.Check the playlist below for a few examples. 

               EIGHT RULES OF PHARMA MARKETING WITH YOUTUBE:

1) DO create a video as short as possible.
Short is sweet , simple and sexy. Ideally keep it between 2 and 4 minutes.

2) DO use descriptive language in the title.
The title is what will get you in the search listings , and ignite your viewers interest.Be sure to write the most interesting and compelling description you can

3) DO choose your thumbnail wisely.
This is the first Visual the viewers would focus on.Get the most visually interesting image you can to use as the thumbnail..

4) DO allow embedding and ratings on your video.   
That will let your video go viral , and prove its popularity.

5) DON’T allow comments on YouTube videos. 
Youtube comments are generally lowbrow.If you want to create dialogue, bring the video onto your own site and invite comments there instead.

6) DO integrate your video(s) with other online efforts
Make your video channel a part of your complete online marketing strategy.

7) DON’T expect people to just find your video through search.
Have an active promotional strategy.

8) DON’T forget to follow all the Regulatory guidelines.
Take care to comply with all the required legal and regulatory language. FDA is getting tougher on such “abuse” of online marketing efforts.

Original post here- 

Also see

Posted in marketing, Video, YouTube | Leave a Comment »

Youtube for pharma marketing.- Best practices

Posted by drneelesh on October 29, 2009

YouTube, LLC
Recently read this post from Rohit Bhargava  titled “10 Rules Of Using YouTube For Pharma & Healthcare Marketing“. Though I don’t back all his logic, i found many of his views very important and worth repeating in another post. I have taken the liberty to add a few extra notes, while editing  many of his.
Youtube is a great channel for marketing and many Pharmaceutical companies are already actively involved.Check the playlist below for a few examples. 

               EIGHT RULES OF PHARMA MARKETING WITH YOUTUBE:

1) DO create a video as short as possible.
Short is sweet , simple and sexy. Ideally keep it between 2 and 4 minutes.
2) DO use descriptive language in the title.
The title is what will get you in the search listings , and ignite your viewers interest.Be sure to write the most interesting and compelling description you can
3) DO choose your thumbnail wisely.
This is the first Visual the viewers would focus on.Get the most visually interesting image you can to use as the thumbnail..
4) DO allow embedding and ratings on your video.   
That will let your video go viral , and prove its popularity.
5) DON’T allow comments on YouTube videos. 
Youtube comments are generally lowbrow.If you want to create dialogue, bring the video onto your own site and invite comments there instead.
6) DO integrate your video(s) with other online efforts
Make your video channel a part of your complete online marketing strategy.
7) DON’T expect people to just find your video through search.
Have an active promotional strategy.
8) DON’T forget to follow all the Regulatory guidelines.
Take care to comply with all the required legal and regulatory language. FDA is getting tougher on such “abuse” of online marketing efforts.
Original post here- 

Posted in marketing, Video, YouTube | Leave a Comment »

Recommended I.T skills for Medicos

Posted by drneelesh on October 28, 2009

Smalltechmeded

Everybody understands that a 21st century Doctor needs to have decent Information technology skills. These IT skills would help in making the person a better clinician, use data more effectively and make fewer errors.But what are the skills needed to make a good doctor?

Below is a presentation enumerating the I.T skills required in a Medical student before admission and at the end of graduation.These have been recommended by 3 top Medical schools under University of California and can serve as good reference guidelines.

http://viewer.docstoc.com/
Recommended IT skills for Medicos

Related article

Posted in E-book, health | Leave a Comment »

FDA regulations for e-marketing of Drugs

Posted by drneelesh on October 27, 2009

:Original raster version: :en::Image:Food and ...
Sales and marketing in the Pharmaceutical industry has always been a very expensive affair, with some people claiming that the industry spends more money on marketing than on R&D.The emergence of internet technologies, and especially Web2.0, has dramatically changed the scope and potential of marketing functions for most industries, except pharmaceuticals. Why?
Because there are NO clear guidelines by the regulatory authorities.

Regulatory guidelines are sorely lacking for direct-to-consumer spending by pharmaceutical companies using internet media Though FDA has been working on this for a long time, no concrete guidelines on Direct-to-Consumer marketing have emerged yet.

Podcast with Dr. Jean Ah Kang, Special Assistant to Tom Abrams at DDMAC in charge of Web 2.0 policy

The pharmaceutical industry is a heavily regulated sector and needs FDA approval for (almost) all their medical communication materials. Though a few companies like Pfizer and Novartis have been wetting their toes in the social media ocean, most are hesitant to take initiative because of absence of guidelines.

Healthcare + Social Media: 2009 Trends and strategy
The dilemma of not having regulatory guidelines for marketing via such tools as Twitter, Face book, blogs and websites, came to a head in April of 2009 when the FDA sent warning letters to 14 companies for search- engine ads that the FDA said violated regulations regarding presentation of fair balance. The industry argues that the regulations requiring disclosure of risk information in print and broadcast advertisements should not be applied to internet ads that only contain 12 words on Google ads, or 140 characters on Twitter.
The U.S. Food and Drug Administration will now hold a two-day public hearing on November 12 and 13 in Washington, on how pharmaceutical companies use the web and social-media tools to market their products,  the first step in a long overdue process that will finally establish guidelines for how drug makers proceed in a Web 2.0 world.
“This meeting and the written comments are intended to  help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools,”
 “Although the agency believes that many issues can be addressed through existing FDA regulations, special characteristics of Web 2.0 and other emerging technologies may require the agency to provide additional guidance to the industry on how the regulations should be applied.”
Very few expect the hearing to provide any solid guidelines so soon, but the inclusion of social media enthusiasts in this  meeting is a very positive sign from the FDA.

Not all are optimistic about the use of Social media in pharmaceutical marketing.Some of them are sitting on the fence while others believe social media tools may not be the path to be followed by Pharmaceuticals.

Related articles-



Posted in Business, marketing, Prescription drug, Web 2.0 | Leave a Comment »

Medical multimedia for presentations

Posted by drneelesh on October 23, 2009

Examples of computer clip art.

Medical Multimedia Resources

 Do you need a piece of clip art to spice up your PowerPoint or web presentation? Or an image of heart rupture, post-infarction? These links will take you to sites containing medicine/health related multimedia. Please note that most of the sites listed permit use of media for educational purposes.

However, it is your responsibility to ensure that you comply with each site’s terms of use.

Clip Art

  • Cheryl’s Image Gallery has nice clip art related to disabilities: people in wheelchairs, crutches, sign language alphabet, parking signs etc.
  • Clips Ahoy has some cartoon-like but well done clip art related to medicine and health.

Photographs and Realistic Illustrations

  • Bristol BioMed Image Archive is an excellent resource. Search or browse by alphabetical listing. Requires free registration to view full size images.

Others

  • HONmedia has over 1,950 medical images and videos, pertaining to 1,350 topics and themes. Easy to use.

Related articles

Posted in Uncategorized | Leave a Comment »

Medical multimedia for presentations

Posted by drneelesh on October 23, 2009

Examples of computer clip art.

Medical Multimedia Resources

 Do you need a piece of clip art to spice up your PowerPoint or web presentation? Or an image of heart rupture, post-infarction? These links will take you to sites containing medicine/health related multimedia. Please note that most of the sites listed permit use of media for educational purposes.

However, it is your responsibility to ensure that you comply with each site’s terms of use.

Clip Art

  • Cheryl’s Image Gallery has nice clip art related to disabilities: people in wheelchairs, crutches, sign language alphabet, parking signs etc.
  • Clips Ahoy has some cartoon-like but well done clip art related to medicine and health.

Photographs and Realistic Illustrations

  • Bristol BioMed Image Archive is an excellent resource. Search or browse by alphabetical listing. Requires free registration to view full size images.

Others

  • HONmedia has over 1,950 medical images and videos, pertaining to 1,350 topics and themes. Easy to use.

Related articles

Posted in Uncategorized | Leave a Comment »

Pfizer for better use of resources-

Posted by drneelesh on October 20, 2009


Pfizer’s huge R&D shop is even bigger now that the company has taken up with Wyeth.Pfizer and Wyeth’s combined R&D budgets now add up to some $11 billion a year.
The added Economics of scale has forced Pfizer Board to consider harsh but intelligent steps to improve profitability.Following a popular trend in the industry, Pfizer will continue to decentralize much of its R&D, which will be spread across 18 different units.

A few examples of changes expected to take place include-

*Wyeth’s pharmaceutical headquarters in Collegeville, Pennsylvania will become the headquarters for Pfizer’s specialty-care unit, which includes vaccines and specialty drugs.

*Wyeth’s corporate headquarters in Madison, New Jersey will now be called, “The Leadership Center for Pfizer Diversified Businesses,”. Employees from several businesses, including animal health, consumer products and nutrition, will work at the site.

*Pfizer said it will keep a “significant presence” in Connecticut. But it’s unclear exactly what that means in terms of numbers. Pfizer employs some 5,000 people in the state.

Even some of its policies are undergoing changes. Like One drug -> Many effects -> More Indications for use ->Better mileage per chemical formulation researched.
 :A unit will be charged with looking at multiple uses of drugs under development throughout the company. That makes a certain amount of sense, given the way many drugs were developed for one use then went on to find success by treating something quite different.
More broadly, certain projects — cancer vaccines, for example—lend themselves to collaborations across different research units. And some functions, such as designing drugs or probing safety risks, can be done company-wide.
Pfizer has been the prime mover in the pharmaceutical industry for a long long time, and the future trends in this industry will take its cue from this exercise.
Related articles

Posted in Uncategorized | Leave a Comment »

Pfizer for better use of resources-

Posted by drneelesh on October 20, 2009


Pfizer’s huge R&D shop is even bigger now that the company has taken up with Wyeth.Pfizer and Wyeth’s combined R&D budgets now add up to some $11 billion a year.
The added Economics of scale has forced Pfizer Board to consider harsh but intelligent steps to improve profitability.Following a popular trend in the industry, Pfizer will continue to decentralize much of its R&D, which will be spread across 18 different units.

A few examples of changes expected to take place include-

*Wyeth’s pharmaceutical headquarters in Collegeville, Pennsylvania will become the headquarters for Pfizer’s specialty-care unit, which includes vaccines and specialty drugs.

*Wyeth’s corporate headquarters in Madison, New Jersey will now be called, “The Leadership Center for Pfizer Diversified Businesses,”. Employees from several businesses, including animal health, consumer products and nutrition, will work at the site.

*Pfizer said it will keep a “significant presence” in Connecticut. But it’s unclear exactly what that means in terms of numbers. Pfizer employs some 5,000 people in the state.

Even some of its policies are undergoing changes. Like One drug -> Many effects -> More Indications for use ->Better mileage per chemical formulation researched.
 :A unit will be charged with looking at multiple uses of drugs under development throughout the company. That makes a certain amount of sense, given the way many drugs were developed for one use then went on to find success by treating something quite different.
More broadly, certain projects — cancer vaccines, for example—lend themselves to collaborations across different research units. And some functions, such as designing drugs or probing safety risks, can be done company-wide.
Pfizer has been the prime mover in the pharmaceutical industry for a long long time, and the future trends in this industry will take its cue from this exercise.

Related articles

Posted in Uncategorized | Leave a Comment »

Digital signage in Healthcare

Posted by drneelesh on October 7, 2009

This document takes a look at use of Digital signage technologies as a communication solution  for Health education/Health marketing/Hospital Branding.

Related articles 

Posted in Communication, digital signage, ebook, hos[itals | Leave a Comment »